A new understanding of the pathogenesis of autoimmunity, the mechanisms of action of
older drugs, the advent of target-specific biological therapies and pharmacogenomics has
created multiple treatment options for the patient with systemic lupus erythematosus. These
include topical therapies, more selective non-steroidal anti-inflammatory agents, hormonal
interventions and a new generation of immune suppressives. Currently available strategies
also include the use of intravenous gamma globulin, apheresis, stem-cell transplantation …